IKT
Inhibikase Therapeutics Inc
2.10$
-1.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | +113.0% | +96.1% | -72.2% | -37.8% | +343.9% | -96.0% | +111.0% | -100.0% | – | |
| – | +107.4% | +107.7% | -30.0% | -65.0% | +1,170.9% | -99.9% | +202,463.6% | -99.8% | +130.3% | |
| – | +152.3% | +1,223.8% | -135.4% | – | +343.9% | -96.2% | -11,544.6% | – | – | |
| – | +107.4% | +107.7% | -30.0% | -65.0% | +1,170.9% | +6.0% | +13.2% | +26.4% | +73.1% | |
| – | – | – | +69.6% | -38.5% | +148.1% | -4.5% | +7.4% | +70.4% | +107.0% | |
| – | +235.8% | -13.9% | +168.5% | -50.5% | +423.9% | +23.6% | -63.1% | +324.3% | +82.0% | |
| – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -18.1% | +18.4% | -32.2% | +273.7% | +0.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | +18.4% | -32.2% | -847.4% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.